VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BAX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BAXBaxter International Inc.
$25.79$13.3B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBAXFinancials

Baxter International Inc. (BAX) Income Statement

30Y historyFree accessUpdated daily

Revenue has held roughly flat near $2.7B to $3.0B while gross margin swung between 19.4% and 35.3% and operating margin ranged from -24.5% to 7.6%, indicating weak cost absorption against SG&A of roughly $700M to $760M per quarter.

Income StatementBalance SheetCash FlowRatios

BAX Income Statement

Annual statement

BAX Income Statement

Baxter International Inc. (BAX) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue11.61B11.24B10.64B10.36B10.06B12.15B11.67B11.36B11.1B10.58B10.16B9.97B10.72B9.41B13.94B13.89B12.84B12.56B12.35B11.26B10.38B9.85B9.51B8.9B8.1B7.36B6.7B6.38B5.71B5.26B5.44B
Revenue Growth %5.33%5.72%2.66%3.01%-17.2%4.05%2.74%2.37%4.87%4.14%1.96%-7.01%13.87%-32.46%0.31%8.18%2.24%1.73%9.63%8.53%5.37%3.58%6.79%9.94%10.1%9.84%4.97%11.81%8.5%-3.29%7.73%
Cost of Goods Sold8.12B7.87B6.65B6.21B6.51B7.43B7.09B6.6B6.34B6.11B6.05B5.82B6.14B5.25B6.8B6.85B6.88B6.04B6.22B5.74B5.64B5.76B5.59B4.95B4.31B3.94B3.64B3.21B2.82B2.57B2.7B
COGS % of Revenue-69.95%62.54%59.94%64.71%61.14%60.7%58.1%57.12%57.73%59.5%58.41%57.26%55.78%48.81%49.28%53.61%48.06%50.36%51%54.36%58.44%58.83%55.6%53.27%53.62%54.37%50.39%49.35%48.87%49.6%
Gross Profit3.49B3.38B3.98B4.15B3.55B4.72B4.59B4.76B4.76B4.47B4.12B4.15B4.58B4.16B7.13B7.05B5.96B6.53B6.13B5.52B4.74B4.09B3.92B3.95B3.79B3.41B3.06B3.17B2.89B2.69B2.74B
Gross Margin %30.09%30.05%37.46%40.06%35.29%38.86%39.3%41.9%42.88%42.27%40.5%41.59%42.74%44.22%51.19%50.72%46.39%51.94%49.64%49%45.64%41.56%41.17%44.4%46.73%46.38%45.63%49.61%50.65%51.13%50.4%
Gross Profit Growth %--15.19%-4%16.93%-24.81%2.9%-3.65%0.04%6.37%8.7%-0.72%-9.5%10.07%-41.66%1.25%18.26%-8.69%6.44%11.07%16.51%15.73%4.55%-0.96%4.44%10.93%11.65%-3.44%9.52%7.47%-1.9%6.28%
Operating Expenses3.71B3.69B3.97B3.44B6.39B3.37B2.97B2.99B3.17B3.19B3.37B3.7B3.92B3.67B4.31B4.1B3.82B3.65B3.57B3.35B2.9B2.45B3.02B2.69B2.26B2.19B2.02B2.02B1.88B1.8B1.83B
OpEx % of Revenue-32.79%37.33%33.23%63.58%27.75%25.45%26.31%28.61%30.1%33.17%37.09%36.62%38.95%30.95%29.51%29.76%29.04%28.88%29.75%27.91%24.92%31.76%30.27%27.86%29.76%30.19%31.58%32.86%34.27%33.65%
Selling, General & Admin2.95B2.89B2.97B2.95B3.1B2.85B2.47B2.54B2.62B2.63B2.73B3.09B3.31B3.08B3.28B3.15B2.91B2.73B2.7B2.52B2.28B2.03B1.96B1.8B1.57B1.44B1.33B1.31B1.21B1.15B1.14B
SG&A % of Revenue-25.7%27.9%28.5%30.79%23.42%21.15%22.31%23.61%24.82%26.81%31.04%30.93%32.76%23.56%22.7%22.63%21.74%21.85%22.38%21.99%20.61%20.61%20.27%19.34%19.58%19.86%20.55%21.17%21.77%21%
Research & Development519M518M590M518M450M531M521M595M654M615M646M603M610M582M1.08B946M915M917M868M760M614M533M517M553M501M426M378M332M323M339M340M
R&D % of Revenue-4.61%5.55%5%4.47%4.37%4.46%5.24%5.89%5.81%6.36%6.05%5.69%6.18%7.76%6.81%7.12%7.3%7.03%6.75%5.92%5.41%5.44%6.21%6.19%5.79%5.64%5.2%5.66%6.45%6.25%
Other Operating Expenses-2M279M413M-28M2.85B-6M-19M-141M-99M-56M0000-51M000070M0-109M543M337M189M323M314M372M344M318M348M
Operating Income-221M-308M14M707M-2.85B1.35B1.62B1.77B1.58B1.29B745M449M656M496M2.82B2.95B2.14B2.88B2.56B2.17B1.84B1.64B895M1.26B1.53B1.22B1.03B1.15B1.01B887M911M
Operating Margin %-1.9%-2.74%0.13%6.82%-28.29%11.11%13.84%15.6%14.27%12.17%7.33%4.5%6.12%5.27%20.24%21.2%16.63%22.9%20.76%19.25%17.74%16.64%9.41%14.13%18.88%16.63%15.44%18.03%17.79%16.87%16.75%
Operating Income Growth %--2300%-98.02%124.85%-310.74%-16.46%-8.8%11.87%22.98%72.89%65.92%-31.55%32.26%-82.42%-4.24%37.92%-25.76%12.21%18.27%17.76%12.32%83.13%-28.86%-17.72%25.02%18.28%-10.09%13.3%14.43%-2.63%11.92%
EBITDA748M673M1.01B1.69B-1.77B2.22B2.44B2.56B2.35B2.04B1.54B1.21B1.45B1.13B3.53B3.62B2.82B3.52B3.19B2.75B2.42B2.22B1.5B1.8B1.97B1.65B1.43B1.52B1.36B1.21B1.26B
EBITDA Margin %6.44%5.99%9.51%16.32%-17.63%18.25%20.89%22.54%21.22%19.26%15.2%12.12%13.51%12.02%25.35%26.03%21.97%27.98%25.87%24.41%23.28%22.53%15.73%20.25%24.3%22.43%21.32%23.86%23.82%22.91%23.15%
EBITDA Growth %-23.05%-33.43%-40.21%195.38%-179.97%-9.1%-4.76%8.75%15.55%31.91%27.9%-16.57%28.03%-67.99%-2.3%28.18%-19.74%10.02%16.22%13.78%8.88%48.33%-17.03%-8.38%19.27%15.55%-6.18%11.99%12.78%-4.29%9.48%
D&A (Non-Cash Add-back)716M981M997M984M1.07B867M823M789M771M750M800M759M792M635M712M670M685M638M631M581M575M580M601M545M439M427M394M372M344M318M348M
EBIT86M-215M119M750M-2.83B1.32B1.45B1.08B1.71B1.19B5.04B574M657M530M2.95B2.9B2B2.85B2.61B2.24B1.84B1.53B1.44B1.59B1.72B1.5B1.32B1.15B1.01B887M911M
Net Interest Income-249M-238M-341M-439M-394M-193M-134M-71M-45M-55M-66M-126M-145M-128M-87M-54M-87M-98M-76M-22M-101M-118M-99M-115M-71M-108M-131M0-193M0-214M
Interest Income36M52M67M69M19M14M19M40M48M30M23M20M22M27M26M38M28M19M72M102M00000000000
Interest Expense285M290M408M508M413M207M153M111M93M85M89M146M167M155M113M92M115M117M148M124M101M118M99M115M71M108M131M0193M0214M
Other Income/Expense34M-197M-303M-465M-403M-234M-324M-802M33M-188M4.21B-21M-166M-121M17M-137M-246M-143M-102M-54M-95M-195M-465M-129M-143M-244M-72M-98M-522M-317M-118M
Pretax Income-187M-505M-289M242M-3.25B1.12B1.29B970M1.62B1.1B4.95B428M490M375M2.84B2.81B1.89B2.73B2.46B2.11B1.75B1.44B430M1.13B1.39B979M962M1.05B493M570M793M
Pretax Margin %-1.61%-4.49%-2.72%2.34%-32.3%9.19%11.07%8.54%14.57%10.39%48.75%4.29%4.57%3.98%20.36%20.22%14.72%21.76%19.94%18.77%16.82%14.66%4.52%12.68%17.11%13.31%14.36%16.49%8.64%10.84%14.58%
Income Tax432M395M37M61M-135M83M182M-41M65M491M-12M35M33M60M555M553M463M519M437M407M348M486M47M222M360M304M208M273M218M199M218M
Effective Tax Rate %-231.02%-78.22%-12.8%25.21%4.16%7.44%14.09%-4.23%4.02%44.64%-0.24%8.18%6.73%16%19.56%19.69%24.5%18.98%17.75%19.25%19.93%33.66%10.93%19.66%25.97%31.05%21.62%25.95%44.22%34.91%27.49%
Net Income-723M-957M-649M2.66B-2.43B1.28B1.1B1B1.55B602M4.96B968M2.5B2.01B2.33B2.22B1.42B2.21B2.01B1.71B1.4B956M388M866M771M612M740M797M315M300M669M
Net Margin %-6.23%-8.51%-6.1%25.64%-24.19%10.57%9.44%8.81%13.93%5.69%48.85%9.71%23.3%21.37%16.69%16.01%11.06%17.55%16.31%15.16%13.45%9.71%4.08%9.73%9.52%8.32%11.05%12.49%5.52%5.7%12.3%
Net Income Growth %-112.02%-47.46%-124.44%209.17%-289.49%16.52%10.09%-35.25%156.81%-87.88%412.91%-61.23%24.11%-13.5%4.59%56.62%-35.6%9.48%17.98%22.28%46.03%146.39%-55.2%12.32%25.98%-17.3%-7.15%153.02%5%-55.16%3.08%
Net Income (Continuing)-619M-900M-326M181M-3.11B1.03B1.11B1.01B1.55B609M4.97B393M457M315M2.28B2.26B1.43B2.21B2.02B1.71B1.4B958M383M907M1.03B675M754M779M275M371M575M
Discontinued Operations-2M-57M-312M2.48B692M262M00-6M-7M-1M575M2.04B1.7B43M00000-1M-2M5M-24M-255M-11M-14M45M40M-71M94M
Minority Interest-27M-27M60M66M62M44M37M30M22M-8M-10M19M36M23M40M243M229M229M0000000000000
EPS (Diluted)-1.39-1.75-1.275.23-4.832.532.131.932.971.089.011.764.563.664.183.882.393.593.162.612.131.520.631.501.661.091.251.350.550.531.23
EPS Growth %-109.25%-37.8%-124.28%208.28%-290.91%18.78%10.36%-35.02%175%-88.01%411.93%-61.4%24.59%-12.44%7.73%62.34%-33.43%13.61%21.07%22.54%40.13%141.27%-58%-9.64%52.29%-12.8%-7.41%145.45%3.77%-56.91%4.24%
EPS (Basic)--1.75-1.275.25-4.832.562.171.973.041.119.091.784.613.704.223.912.413.633.222.652.151.540.631.511.711.131.271.380.560.541.23
Diluted Shares Outstanding520M513M510M506M504M508M517M519M546M555M551M549M547M549M556M573M594M614M637M654M656M629M618M577.33M464.46M561.47M592M590M578M564M552M
Basic Shares Outstanding517M513M510M506M504M502M509M509M534M543M546M545M542M543M551M569M590M607M625M644M651M622M614M573.51M450.88M541.59M582.68M580M568M556M544M
Dividend Payout Ratio---22.06%-41.28%42.92%42.26%24.32%52.33%5.4%94.01%43.85%50.84%34.57%31.88%48.45%28.66%27.11%41.24%-----------

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetStrained
Cash FlowMixed
Top Statement Risk

Leverage and persistent negative margins

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Stabilizing After Volatile Stretch

Based on Baxter's reported quarterly figures, revenue has held roughly flat near $2.7B to $3.0B over ten quarters, with year-over-year growth of about 3% to 8% in recent periods suggesting a modest, though not yet accelerating, top-line recovery.

The sequential revenue pattern appears steady rather than expanding, which suggests the core consumables base is holding up while capital equipment exposure may be dampening upside. Recent growth rates of 5.0% and 5.3% are respectable but do not yet demonstrate the volume-driven acceleration needed to offset ongoing portfolio transformation effects. Investors should monitor whether this trajectory persists once divestiture-related revenue reclassifications distort comparisons.

Gross Margin Recovers Then Compresses

As reported in the quarterly income statements, Baxter's gross margin ranged from roughly 33% to 35% across recent quarters after dipping to 19.4% in 2025Q4, indicating meaningful sensitivity to charges or mix shifts rather than a stable structural level.

The gross margin trough in the fourth quarter of 2025 appears too deep to reflect ordinary input cost fluctuation alone, which may point to one-time items or inventory-related adjustments that warrant further investigation. The recovery to roughly 33% to 35% in 2026 is encouraging but remains below the 38% levels seen in 2024, suggesting that pricing power or product mix has not fully rebounded. This pattern is consistent with a business exposed to raw material and logistics inflation that has not yet been fully passed through.

Operating Leverage Remains Elusive

Based on Baxter's reported figures, SG&A has stayed near $700M to $760M per quarter while gross profit fluctuated, leaving operating margin in a range of roughly -24.5% to 7.6%, signaling weak cost absorption at current revenue levels.

Because SG&A is largely fixed in dollar terms, the operating income swings track gross profit movements almost one for one, which indicates that overhead is not yet being leveraged as revenue scales. The most recent quarter's 7.6% operating margin is a meaningful improvement, but it arrives alongside a tariff refund that may have flattered the result. Sustained operating leverage would require SG&A to grow materially slower than gross profit over multiple quarters.

Headline Earnings Beat Needs Scrutiny

According to reported results, Baxter's latest quarter delivered diluted EPS of $0.57 against an operating margin of 7.6% and net margin of 9.9%, with net margin exceeding operating margin suggesting non-operating or one-time items contributed to the reported profit.

The net margin running ahead of operating margin implies that below-the-line items, including the tariff refund referenced in recent context, are materially supporting reported earnings. Stock-based compensation is modest at roughly $30M per quarter, so it does not appear to be the source of distortion here. Investors should treat the headline beat as partially non-recurring until operating income is shown to sustain similar levels excluding these items.

Negative Quarters Challenge the Recovery

Based on Baxter's reported history, the company posted net losses in four of the last ten quarters, including a $1.1B loss in 2025Q4, which suggests that the current profitable stretch may be fragile and heavily dependent on non-recurring support.

Short-side critics would likely point to the repeated pattern of large charges and negative net margins as evidence that restructuring is a recurring cost of doing business rather than a one-off event. The Vantive separation, the Hillrom integration, and sustained net margin deterioration warrant monitoring for signs that transformation costs keep reappearing. Without clearer evidence of clean operating earnings, the recovery narrative remains unproven.

BAX — Frequently Asked Questions

Quick answers to the most common questions about buying BAX stock.

What was Baxter International Inc.'s (BAX) revenue in 2025?

For fiscal year 2025, Baxter International Inc. (BAX) reported total revenue of $11.24B. This represents a 106.8% increase compared to $5.44B in 1996.

Is Baxter International Inc. (BAX) profitable?

Baxter International Inc. (BAX) reported a net loss of $957.0M for the fiscal year ending 2025.

What is Baxter International Inc.'s operating profit margin?

Baxter International Inc. (BAX) reported an operating income of $-308.0M, resulting in an operating profit margin of -2.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Baxter International Inc.'s gross profit and gross margin?

Baxter International Inc. (BAX) generated $3.38B in gross profit for the year, representing a gross profit margin of 30.1%. This demonstrates the company's core pricing power and production efficiency.